Metropolis Healthcare Sustainability Profile
Metropolis Healthcare Limited, commonly referred to as Metropolis, is a leading diagnostic service provider headquartered in India. Established in 1980, the company has grown to become a prominent player in the healthcare industry, with a strong presence across major operational regions including Mumbai, Delhi, and Bengaluru. Specialising in pathology and diagnostic services, Metropolis offers a comprehensive range of tests, including advanced molecular diagnostics and preventive health check-ups. Their commitment to quality and innovation sets them apart, as they utilise state-of-the-art technology and adhere to stringent quality standards. With over four decades of experience, Metropolis has achieved significant milestones, including numerous accreditations and a vast network of laboratories and collection centres. This positions them as a trusted name in the healthcare sector, dedicated to enhancing patient care through accurate and timely diagnostics.
DitchCarbon Score
How does Metropolis Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Metropolis Healthcare's score of 21 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Metropolis Healthcare's reported carbon emissions
In 2023, Metropolis Healthcare reported total carbon emissions of approximately 6,825,350 kg CO2e from Scope 2, 317,680 kg CO2e from Scope 1, and 44,000 kg CO2e from Scope 3. This data reflects a comprehensive approach to emissions reporting, with all three scopes disclosed. Comparatively, in 2022, the company recorded emissions of about 9,815,380 kg CO2e for Scope 2, 220,950 kg CO2e for Scope 1, and 218,000 kg CO2e for Scope 3. This indicates a significant reduction in Scope 2 emissions, which decreased by approximately 1,990,030 kg CO2e year-on-year. Despite these reductions, Metropolis Healthcare has not set specific science-based targets for emissions reduction, nor have they made any formal climate pledges. The absence of documented reduction initiatives suggests a need for further commitment to climate action. The emissions data is not cascaded from any parent organization, indicating that Metropolis Healthcare Limited independently reports its carbon footprint. The company continues to focus on improving its sustainability practices in the healthcare sector, aligning with industry standards for climate accountability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 220,950 | 000,000 |
| Scope 2 | 9,815,380 | 0,000,000 |
| Scope 3 | 218,000 | 00,000 |
How Carbon Intensive is Metropolis Healthcare's Industry?
How Carbon Intensive is Metropolis Healthcare's Location?
Metropolis Healthcare's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Metropolis Healthcare has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
